Brief: Diasorin FY Adjusted EBITDA EUR 394 Mln
20/03/2026 16:47
March 20 (Reuters) - DiaSorin SpA DIAS.MI: PROPOSES ORDINARY DIVIDEND OF €1.30 PER SHARE, UP 8.3% VERSUS 2024 SEES 2026 REVENUE GROWTH OF 5%-6% AND EBITDA ADJUSTED MARGIN OF 32%-33% FY ADJUSTED EBITDA EUR 394 MILLION FY REVENUE EUR 1.195 BILLION GROUP FY ADJUSTED NET PROFIT EUR 223 MILLION Further company coverage: DIAS.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on DiaSorin SpA
See all newsKepler sees European Medtech recovery, starts BioMerieux at 'Buy' as top pick
Brief: Diasorin Receives Us' FDA 510(K) Clearance And Clia Waiver For Liaison Nes Group A Streptococcus (Gas) Assay
Deutsche Bank cuts Diasorin to 'sell', sees company targets as stretched
Italy - Factors to watch on June 5
Italy's DiaSorin jumps after Betaville reports possible takeover interest